Literature DB >> 24356267

[The broad phenotypic spectrum of SCA-3: hereditary spastic paraplegia].

Sergio A Rodríguez-Quiroga1, Dolores González-Morón, Tomoko Arakaki, Nélida Garreto, Marcelo A Kauffman.   

Abstract

Machado-Joseph disease (MJD) is the most frequent dominantly inherited spinocerebellar ataxia. A marked phenotypic variability is a characteristic of this disorder that could involve non-cerebellar presentations. Based on several case reports describing pyramidal dysfunction as the main symptom at onset, a clinical form resembling hereditary spastic paraplegia has been proposed. We report here two further cases of MJD patients whose initial clinical presentation suggested hereditary spastic paraplegia, and a summary of the main findings of previously similar published reports. Our findings lent support to the proposal of a MJD subtype distinguished by a marked pyramidal dysfunction at onset, simulating a clinical picture of hereditary spastic paraplegia.

Entities:  

Keywords:  Machado Joseph disease; SCA-3; ataxia; genetics; hereditary spastic paraplegia

Mesh:

Substances:

Year:  2013        PMID: 24356267

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  2 in total

1.  Neurogenetics in Argentina: diagnostic yield in a personalized research based clinic.

Authors:  Sergio Alejandro Rodríguez-Quiroga; Marta Cordoba; Dolores González-Morón; Nancy Medina; Patricia Vega; Cecilia Vazquez Dusefante; Tomoko Arakaki; Nélida Susana Garretto; Marcelo Andres Kauffman
Journal:  Genet Res (Camb)       Date:  2015       Impact factor: 1.588

2.  Overwhelming genetic heterogeneity and exhausting molecular diagnostic process in chronic and progressive ataxias: facing it up with an algorithm, a gene, a panel at a time.

Authors:  J Perez Maturo; L Zavala; P Vega; D González-Morón; N Medina; V Salinas; J Rosales; M Córdoba; T Arakaki; N Garretto; S Rodríguez-Quiroga; M A Kauffman
Journal:  J Hum Genet       Date:  2020-06-03       Impact factor: 3.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.